Loading...
Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain
OBJECTIVE: To evaluate the budget impact and the direct costs of the introduction of subcutaneous belimumab (SC) into the Spanish National Health Service (NHS) for patients with systemic lupus erythematosus (SLE) in Spain. METHODS: This study was conducted from the Spanish NHS perspective with a tim...
Na minha lista:
| Udgivet i: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6901000/ https://ncbi.nlm.nih.gov/pubmed/31824182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S218464 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|